A series of novel diphenyl-1,3-oxazoline compounds designed as chitin synthase I inhibitors for acaricidal applications. These molecules target mite eggs and larvae, offering a potential new approach to pest management through disruption of chitin biosynthesis in arthropods.
This research presents a library of novel 2,4-diphenyl-1,3-oxazoline and 2,5-diphenyl-1,3-oxazoline compounds bearing varied substituents at the para position of the 4-phenyl or 5-phenyl ring. The compounds are being developed and evaluated for acaricidal activity, with particular focus on efficacy against mite eggs and larvae. The underlying strategy targets chitin synthase I, an enzyme essential for chitin formation in arthropod exoskeletons and egg shells. By inhibiting this pathway, the compounds aim to disrupt mite development at early life stages. The project also seeks to compare the acaricidal performance of the two structural isomers to determine which scaffold delivers superior biological activity.
Core chemistry:
Mechanism of action:
Evaluation focus:
The compounds are at an early research stage. Molecular design and synthesis have been completed, and the acaricidal evaluation plan is established. The hypothesis that both isomers share a comparable binding mode to chitin synthase I remains to be validated through biological assays. Comparative testing of the 2,4- and 2,5-diphenyl series against mite eggs and larvae is the next critical step toward demonstrating proof of concept and advancing toward potential agricultural or veterinary applications.
Nankai University is a comprehensive public research university in Tianjin, serving a large student body and aligning fundamental inquiry with applied impact. Industry ties run through joint research platforms with municipal and corporate partners, on-campus facilities for collaborative R&D, and a technology transfer office for IP and licensing. Proximity to the Tianjin Binhai New Area and the TEDA development zone places researchers near advanced manufacturing and port logistics, enabling pilots and supplier access. Research is backed by competitive funding from national agencies in China, including the National Natural Science Foundation of China and the Ministry of Science and Technology, plus provincial and municipal programs. Commercialization services help launch startups and connect inventions with established enterprises.